{"schema_version":"secwatch.filing_event.v1","accession":"0001746473-24-000084","form_type":"8-K","ticker":"PLRX","cik":"0001746473","company_name":"PLIANT THERAPEUTICS, INC.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.869225+00:00","generated_at":"2026-06-01T04:22:14.985402+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Pliant Therapeutics say-on-pay vote fails; Krognes appointed to board","bullets":["Non-binding say-on-pay vote failed: 23,479,353 for, 28,329,655 against, 10,277 abstain.","Steve Krognes appointed as Class III director and Audit Committee chair; receives option for 53,528 shares vesting over 3 years.","Board size increased from 10 to 11 members to accommodate Krognes.","Deloitte & Touche LLP ratified as auditor for FY2024: 56,628,368 for, 10,853 against, 62,998 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001746473-24-000084","json":"https://secwatch.observer/filing/0001746473-24-000084.json","markdown":"https://secwatch.observer/filing/0001746473-24-000084.md","text":"https://secwatch.observer/filing/0001746473-24-000084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1746473/000174647324000084/0001746473-24-000084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1746473/000174647324000084/plrx-20240613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:22:14.985402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}